EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2

Franca Orsini iD, Marco Bosica, Annacarla Martucci, Massimiliano De Paola, Davide Comolli iD, Rosaria Pascente, Gianluigi Forloni, Paul E Fraser, Ottavio Arancio iD, Luana Fioriti iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Franca Orsini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, MI, Italy. Hauptthemen laut MEDLINE: tau Proteins, Sumoylation, Hippocampus, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Alzheimer's Association, Alzheimer’s Association Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurologic manifestations are an immediate consequence of SARS-CoV-2 infection, the etiologic agent of COVID-19, which, however, may also trigger long-term neurological effects. Notably, COVID-19 patients with neurological symptoms show elevated levels of biomarkers associated with brain injury, including Tau proteins linked to Alzheimer’s pathology. Studies in brain organoids revealed that SARS-CoV-2 alters the phosphorylation and distribution of Tau in infected neurons, but the mechanisms are currently unknown. We hypothesize that these pathological changes are due to the recruitment of Tau into stress granules (SGs) operated by the nucleocapsid protein (NCAP) of SARS-CoV-2. To test this hypothesis, we investigated whether NCAP interacts with Tau and localizes to SGs in hippocampal neurons in vitro and in vivo. Mechanistically, we tested whether SUMOylation, a posttranslational modification of NCAP and Tau, modulates their distribution in SGs and their pathological interaction. We found that NCAP and Tau colocalize and physically interact. We also found that NCAP induces hyperphosphorylation of Tau and causes cognitive impairment in mice infected with NCAP in their hippocampus. Finally, we found that SUMOylation modulates NCAP SG formation in vitro and cognitive performance in infected mice. Our data demonstrate that NCAP induces Tau pathological changes both in vitro and in vivo. Moreover, we demonstrate that SUMO2 ameliorates NCAP-induced Tau pathology, highlighting the importance of the SUMOylation pathway as a target of intervention against neurotoxic insults, such as Tau oligomers and viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsSumoylationHippocampusCOVID-19SARS-CoV-2Coronavirus Nucleocapsid ProteinsNeuronsAnimalsMiceHumansPhosphorylationSmall Ubiquitin-Related Modifier ProteinsStress GranulesMice, Inbred C57BLPhosphoproteinsMaleNucleocapsid ProteinsCognitive Dysfunction

Stichwörter der Autor:innen

SARS-CoV-2SUMOmemorynucleocapsid proteinstress granulessynapsestau

Substanzen

tau ProteinsCoronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2Small Ubiquitin-Related Modifier ProteinsSUMO2 protein, mousePhosphoproteinsNucleocapsid Proteins

Autor:innen und Institutionen

  • Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, MI, Italy.
  • Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 2S8, Canada.
  • Department of Pathology and Cell Biology, Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA.

ORCID-Profile: Franca Orsini, Davide Comolli, Ottavio Arancio, Luana Fioriti

Förderung

  • NINDS NIH HHS
  • Alzheimer's Association
  • Alzheimer’s Association Research Grant
  • Alzheimer’s Association Research Fellowship

Zitieren

APA

Orsini, F., Bosica, M., Martucci, A., De Paola, M., Comolli, D., Pascente, R., Forloni, G., Fraser, P. E., Arancio, O., & Fioriti, L. (2024). SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137169

Vancouver

Orsini F, Bosica M, Martucci A, De Paola M, Comolli D, Pascente R, et al. SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137169

BibTeX
@article{Orsini2024,
  author = {Orsini, Franca and Bosica, Marco and Martucci, Annacarla and De Paola, Massimiliano and Comolli, Davide and Pascente, Rosaria and Forloni, Gianluigi and Fraser, Paul E and Arancio, Ottavio and Fioriti, Luana},
  title = {SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137169}
}
Kostenlos starten →